In HT-29 and HCT116 cells, lobaplatin induces pyroptosis via the activation of caspase-3 and GSDME, which provided evidence that lobaplatin eradicate CRC cells via proptosis (Figure 3C) [120]. Here, GSDME is linked to colorectal carcinoma.